Jacob Lowry
Surgical Critical Care · Valhalla, NYNPI 1568966398
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 60 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Integra Lifesciences Corporation at 44.1% of the total. 2025 is the largest year on record at $737, more than ten times the $16 reported in 2020.
Across 60 payments — averaging $39.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$1K
- Johnson & Johnson$565
- Davol Inc.$141
- Aroa Biosurgery Incorporated$85
- Baxter Healthcare$83
- Kerecis Limited$81
- plus $382 from 14 others
What the payments were for
- Food & beverage$2,390100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integra Lifesciences Corporation | 15 | $1,053 |
| Johnson & Johnson(2 entities) | 13 | $565 |
| Davol Inc. | 1 | $141 |
| Aroa Biosurgery Incorporated | 6 | $85 |
| Baxter Healthcare | 4 | $83 |
| Kerecis Limited | 3 | $81 |
| Solventum Corporation | 3 | $56 |
| Haemonetics Corporation | 2 | $45 |
| CSL Behring | 2 | $42 |
| Medline Industries LP | 1 | $35 |
| Biocomposites Inc | 1 | $26 |
| AbbVie | 1 | $25 |
| Avanos Medical | 1 | $23 |
| Sanara Medtech Inc. | 1 | $23 |
| BTG International Inc. | 1 | $22 |
| Lifenet Health | 1 | $20 |
| Innovation Technologies Inc | 1 | $18 |
| Teleflex LLC | 1 | $17 |
| La Jolla Pharmaceutical Company | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTEGRA$1,424
- INTEGRA DERMAL REGENERATION TEMPLATE$437
- PRIMATRIX$437
- MATRIXRIB$246
- Phasix Mesh$141
How this compares
$2,390 in reported general payments places this provider in the 55th percentile of 118 surgical critical care providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 20 | $164 |
| Oxycodone Hcl | 14 | $56 |
Paid to pharmacies, not to this prescriber.
Other surgical critical care in Valhalla
- Ilya ShnaydmanValhalla$24K
- Kartik PrabhakaranValhalla$22K
- William MarshallValhalla$17K
- Matthew BronsteinValhalla$15K
- Joshua KleinValhalla$10K
- Jordan KirschValhalla$6K
- Bardiya Zangbar SabeghValhalla$6K
- Aaron ZuckermanValhalla$4K
- Peter RheeValhalla$4K
- Mohammad GilaniBrooklyn$53K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.